Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.
Official title: A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis
Key Details
Gender
All
Age Range
5 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-03-13
Completion Date
2031-03-04
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
Deucravacitinib
Specified dose on specified days
Placebo
Specified dose on specified days
Locations (47)
Local Institution - 0038
Lancaster, California, United States
Local Institution - 0020
Chicago, Illinois, United States
Local Institution - 0023
Indianapolis, Indiana, United States
Local Institution - 0059
North New Hyde Park, New York, United States
Local Institution - 0065
Cincinnati, Ohio, United States
Local Institution - 0066
Cleveland, Ohio, United States
Local Institution - 0036
Austin, Texas, United States
Local Institution - 0068
Fortaleza, Ceará, Brazil
Local Institution - 0032
Cuiabá, Mato Grosso, Brazil
Local Institution - 0030
Belo Horizonte, Minas Gerais, Brazil
Local Institution - 0013
Curitiba, Paraná, Brazil
Local Institution - 0072
Curitiba, Paraná, Brazil
Local Institution - 0007
Recife, Pernambuco, Brazil
Local Institution - 0033
Porto Alegre, Rio Grande do Sul, Brazil
LMK Serviços Médicos S/S
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0069
Xangri-lá, Rio Grande do Sul, Brazil
Local Institution - 0073
Vila Clementino, São Paulo-SP, Brazil
Local Institution - 0027
Rio de Janeiro, Brazil
Local Institution - 0047
São Paulo, Brazil
Local Institution - 0010
São Paulo, Brazil
University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD
Plovdiv, Bulgaria
Local Institution - 0062
Sofia, Bulgaria
Local Institution - 0074
Beijing, Beijing Municipality, China
Local Institution - 0049
Beijing, Beijing Municipality, China
The Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China
Childrens Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
The First Hospital of Jilin University
Changchun, Jilin, China
The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Children's Hospital of Fudan University
Shanghai, China
Fakultni nemocnice Olomouc
Olomouc, Olomoucký kraj, Czechia
Fakultni nemocnice v Motole
Prague, Praha 5, Czechia
Kinderklinik des Uni-Klinikums Erlangen
Erlangen, Germany
Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari
Hamburg, Germany
University of Naples Federico II
Naples, Campania, Italy
Azienda Ospedaliera Universitaria Meyer IRCCS
Florence, Tuscany, Italy
Local Institution - 0017
San Juan, Puerto Rico
Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca
Cluj-Napoca, Cluj, Romania
Local Institution - 0048
Iași, Iaşi, Romania
Sc Medaudio-Optica Srl
Râmnicu Vâlcea, Vâlcea County, Romania
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [Barcelona], Spain
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, Spain
Hospital Universitari i Politecnic La Fe
Valencia, Spain
Istanbul Universitesi Cerrahpasa
Istanbul- Fatih, Istanbul, Turkey (Türkiye)
Local Institution - 0061
Ankara, Turkey (Türkiye)
Local Institution - 0044
Ankara, Turkey (Türkiye)
Umraniye Training and Research Hospital
Istanbul, Turkey (Türkiye)